SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla surges on getting nod to invest upto $100 million in Cipla (EU)

20 Mar 2026 Evaluate

Cipla is currently trading at Rs. 1263.00, up by 24.35 points or 1.97% from its previous closing of Rs. 1238.65 on the BSE.

The scrip opened at Rs. 1248.65 and has touched a high and low of Rs. 1264.00 and Rs. 1248.65 respectively. So far 5645 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1672.20 on 23-Oct-2025 and a 52 week low of Rs. 1,242.65 on 19-Mar-2026.

Last one week high and low of the scrip stood at Rs. 1327.85 and Rs. 1242.65 respectively. The current market cap of the company is Rs. 102018.91 crore.

The promoters holding in the company stood at 29.21%, while Institutions and Non-Institutions held 54.64% and 16.14% respectively.

Cipla has received approval from board of directors for investment upto $100 million in the equity share capital of Cipla (EU), a wholly- owned subsidiary of the Company for the purpose of providing onward financial assistance to InvaGen Pharmaceuticals Inc., wholly-owned subsidiary of Cipla (EU), to meet its capital expenditure, working capital requirements and other general corporate purposes.

The board at its meeting held on March 19, 2026 has approved the same. 

Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×